A. J. Oude Ophuis

Cohort profile of BIOMArCS: the BIOMarker study to identify the Acute risk of a Coronary Syndrome—a prospective multicentre biomarker study conducted in the Netherlands

R. D. de Winter, R. J. Winter, P. Harst, 2016, BMJ Open.

Edoxaban versus Warfarin in Patients with Atrial Fibrillation in Relation to the Risk of Stroke: A Secondary Analysis of the ENGAGE AF-TIMI 48 Study.

E. Antman, R. Giugliano, S. Murphy, 2021, American heart journal.

Stabilization patterns and variability of hs-CRP, NT-proBNP and ST2 during 1 year after acute coronary syndrome admission: results of the BIOMArCS study

P. Harst, H. Crijns, P. van der Harst, 2020, Clinical chemistry and laboratory medicine.

Temporal Evolution of Serum Concentrations of High‐Sensitivity Cardiac Troponin During 1 Year After Acute Coronary Syndrome Admission

R. D. de Winter, M. Simoons, P. van der Harst, 2020, Journal of the American Heart Association.

High-Frequency Biomarker Measurements of Troponin, NT-proBNP, and C-Reactive Protein for Prediction of New Coronary Events After Acute Coronary Syndrome.

R. D. de Winter, M. Simoons, P. van der Harst, 2019, Circulation.

Details on high frequency blood collection, data analysis, available material and patient characteristics in BIOMArCS

R. D. de Winter, P. van der Harst, E. Boersma, 2019, Data in brief.

The temporal pattern of immune and inflammatory proteins prior to a recurrent coronary event in post-acute coronary syndrome patients

E. Boersma, R. Oemrawsingh, I. Kardys, 2018, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.